Plasma Concentration Monitoring of Busulfan: Does It Improve Clinical Outcome?

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.39, Iss.2, 2000-08, pp. : 155-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can Pharmacokinetic Monitoring Improve Clinical Use of Fluorouracil?

By Young A.M. Daryanani S. Kerr D.J.

Clinical Pharmacokinetics, Vol. 36, Iss. 6, 1999-06 ,pp. : 391-398

Adis International

Access to resources Recommend Favorite

Does Olanzapine Warrant Clinical Pharmacokinetic Monitoring in Schizophrenia?

By Schwenger Erin Dumontet Jane Ensom Mary H.H.

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 415-428

Adis International

Access to resources Recommend Favorite

Does guideline adherence improve antibacterial therapy?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Risperidone Drug Monitoring: A Useful Clinical Tool?

By Odou P.

Clinical Drug Investigation, Vol. 19, Iss. 4, 2000-04 ,pp. : 283-292

Adis International

Access to resources Recommend Favorite

Does the Angiotensin II Receptor Antagonist Losartan Improve Cognitive Function?

By Tedesco M.A. Ratti G. Di Salvo G. Natale F.

Drugs & Aging, Vol. 19, Iss. 10, 2002-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite